EE465 Cost-Effectiveness of Sotrovimab for the Treatment of Mild-to-Moderate COVID-19 in Patients at High Risk of Disease Progression in Italy
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.710
https://www.valueinhealthjournal.com/article/S1098-3015(22)02914-X/fulltext
Title :
EE465 Cost-Effectiveness of Sotrovimab for the Treatment of Mild-to-Moderate COVID-19 in Patients at High Risk of Disease Progression in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02914-X&doi=10.1016/j.jval.2022.09.710
First page :
Section Title :
Open access? :
No
Section Order :
10248